Venaxis files for CE Mark approval for European commercialization

Venaxis files for CE Mark approval for European commercialization

CASTLE ROCK - Venaxis Inc. (Nasdaq: APPY) has filed for CE Mark approval in Europe for APPY 1, its blood-based appendicitis test, the company announced. Venaxis said it expects to obtain CE... Read More

By: Steve Wednesday December 26, 2012 Tags: appendicitis, APPY 1, Castle Rock, CE Mark, Don Hurd, Venaxis

IN Sponsors

Content Garden ad

Browse

InnovatioNews ends 9-year run covering Colorado innovation
A New Sunrise. Stakeholders all await, shapes a path to success too few even see. How often you get & answer questions is one indicator of your readiness
A New Sunrise. Stakeholders all await, shapes a path to success too few even see. How often you get & answer questions is one indicator of your readiness
InnovatioNews on Spring hiatus until May 13
InnovatioNews on Spring hiatus until May 13
The Coming Drone Delivery Revolution – What Comes Next?
The Coming Drone Delivery Revolution – What Comes Next?
Primavera Essentials introduces Neuro-Eze
Primavera Essentials introduces Neuro-Eze

Entrepreneurial by Nature


Colorado Entreprenerial by Nature
Copyright InnovatioNews LLC 2015. All Rights Reserved.